LGA
CVS icon

Lebenthal Global Advisors’s CVS Health CVS Stock Holding History

Lebenthal Global Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,136
Closed -$250K – 184
2024
Q1 		$250K Buy
3,136
+88
+3% +$6.72K 0.06% 173
2023
Q4 		$241K Buy
+3,048
New +$217K 0.06% 175
2023
Q1 		– Sell
-3,329
Closed -$310K – 120
2022
Q4 		$310K Buy
3,329
+280
+9% +$27K 0.1% 105
2022
Q3 		$290K Sell
3,049
-71
-2% -$7.03K 0.13% 92
2022
Q2 		$289K Buy
3,120
+1,124
+56% +$110K 0.14% 103
2022
Q1 		$202K Buy
+1,996
New +$210K 0.09% 141
2021
Q1 		– Sell
-1,700
Closed -$116K – 221
2020
Q4 		$116K Buy
+1,700
New +$111K 0.08% 160

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Lebenthal Global Advisors's CVS Position: Q2 2024 in Review

Lebenthal Global Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,136 shares — an estimated $250K sold.

Lebenthal Global Advisors first reported a position in CVS in Q4 2020 and held it in 7 quarters. The position peaked at $310K in Q4 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Lebenthal Global Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Lebenthal Global Advisors sold 3,136 CVS Health shares in Q2 2024, an estimated $250K.
  • Lebenthal Global Advisors first reported a position in CVS Health in Q4 2020 and held it in 7 quarters.
  • Lebenthal Global Advisors's CVS Health position peaked at $310K in Q4 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Lebenthal Global Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.